header logo image

Buy, Sell or Hold? Analysts Approach: Innoviva (INVA), Puma Biotechnology (PBYI)? – The USA Commerce

March 28th, 2017 1:43 pm
Buy, Sell or Hold? Analysts Approach: Innoviva (INVA), Puma Biotechnology (PBYI)?
The USA Commerce
Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) dropped -2.02% to $38.90. During the trading on 03/27/2017, Company's stock ranged from $39.70 to $38.15. The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) ...
Watch List: Puma Biotechnology Inc (NASDAQ:PBYI) , Red Rock Resorts, Inc (NASDAQ:RRR)NYSE Journal (press release)

all 3 news articles »

See the original post here:
Buy, Sell or Hold? Analysts Approach: Innoviva (INVA), Puma Biotechnology (PBYI)? - The USA Commerce

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick